An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice (Q37522916)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 2009

Language	Label	Description	Also known as
English	An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice	scientific article published on July 2009

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice (English)

1 reference

Europe PubMed Central

20 August 2017

0 references

23

object named as

Mike D Thomas

1 reference

Europe PubMed Central

20 August 2017

object named as

Helen K Reddel

1

0 references

object named as

Ian D Pavord

17

0 references

object named as

Paul M O'Byrne

15

0 references

Louis-Philippe Boulet

4

object named as

Louis-Philippe Boulet

1 reference

Europe PubMed Central

20 August 2017

Stanley J Szefler

22

object named as

Stanley J Szefler

1 reference

Europe PubMed Central

20 August 2017

William W Busse

6

object named as

William W Busse

1 reference

Europe PubMed Central

20 August 2017

18

object named as

Malcolm R Sears

1 reference

Europe PubMed Central

20 August 2017

2

object named as

D Robin Taylor

1 reference

Europe PubMed Central

20 August 2017

Stuart W. Stoloff

20

object named as

Stuart W Stoloff

1 reference

Europe PubMed Central

20 August 2017

Johan C de Jongste

11

object named as

Johan C de Jongste

1 reference

Europe PubMed Central

20 August 2017

author name string

Eric D Bateman

3

1 reference

Europe PubMed Central

20 August 2017

Homer A Boushey

5

1 reference

Europe PubMed Central

20 August 2017

Thomas B Casale

7

1 reference

Europe PubMed Central

20 August 2017

Pascal Chanez

8

1 reference

Europe PubMed Central

20 August 2017

Paul L Enright

9

1 reference

Europe PubMed Central

20 August 2017

Peter G Gibson

10

1 reference

Europe PubMed Central

20 August 2017

Huib A M Kerstjens

12

1 reference

Europe PubMed Central

20 August 2017

Stephen C Lazarus

13

1 reference

Europe PubMed Central

20 August 2017

Mark L Levy

14

1 reference

Europe PubMed Central

20 August 2017

Martyn R Partridge

16

1 reference

Europe PubMed Central

20 August 2017

Peter J Sterk

19

1 reference

Europe PubMed Central

20 August 2017

Sean D Sullivan

21

1 reference

Europe PubMed Central

20 August 2017

Sally E Wenzel

24

1 reference

Europe PubMed Central

20 August 2017

American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations

25

1 reference

Europe PubMed Central

20 August 2017

language of work or name

0 references

publication date

1 July 2009

1 reference

Europe PubMed Central

20 August 2017

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

20 August 2017

180

1 reference

Europe PubMed Central

20 August 2017

59-99

1 reference

Europe PubMed Central

20 August 2017

1

1 reference

Europe PubMed Central

20 August 2017

A new perspective on concepts of asthma severity and control.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

An international observational prospective study to determine the cost of asthma exacerbations (COAX).

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Asthma mortality in the Danish child population: risk factors and causes of asthma death.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Optimal asthma control, starting with high doses of inhaled budesonide.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effectiveness and safety of salmeterol in nonspecialist practice settings

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Risk factors of frequent exacerbations in difficult-to-treat asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Omalizumab is effective in the long-term control of severe allergic asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

A randomized trial of peak-flow and symptom-based action plans in adults with moderate-to-severe asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Compliance with peak expiratory flow monitoring in home management of asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Peak flow monitoring for guided self-management in childhood asthma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The need for standardisation of peak flow charts.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Counting, analysing and reporting exacerbations of COPD in randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Clinical phenotypes of asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Asthma: defining of the persistent adult phenotypes

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Traditional and patient-centred outcomes with three classes of asthma medication.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Asthma severity: a factor analytic investigation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Interpreting thresholds for a clinically significant change in health status in asthma and COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Perception of asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Assessment of variations in control of asthma over time.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Classifying asthma severity: prospective symptom diary or retrospective symptom recall?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Measuring asthma control. Clinic questionnaire or daily diary?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Analysis of adherence to peak flow monitoring when recording of data is electronic

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Validation of an asthma symptom diary for interventional studies

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The use of handheld computers in clinical trials

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Pitfalls in processing home electronic spirometric data in asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Electronic diaries and questionnaires: designing user interfaces that are easy for all patients to use.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

School-based asthma surveillance: a comparison of student and parental report

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Wheeze detection: recordings vs. assessment of physician and parent.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Parental understanding of wheeze and its impact on asthma prevalence estimates.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Randomized controlled trial of fluticasone in preschool children with intermittent wheeze

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Correlation between objective measures of airway calibre and clinical symptoms in asthma: a systematic review of clinical studies

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

House dust mite barrier bedding for childhood asthma: randomised placebo controlled trial in primary care [ISRCTN63308372]

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Double blind randomised controlled trial of two different breathing techniques in the management of asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Medications used by children with asthma living in the inner city

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Measured bronchodilator use in preschool children with asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Home spirometry and asthma severity in children.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

General considerations for lung function testing.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effect of the number of peak expiratory flow readings per day on the estimation of diurnal variation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Standardization of ambulatory peak flow monitoring: the importance of recent beta2-agonist inhalation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Asthma stability after oral prednisone: a clinical model for comparing inhaled steroid potency

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Does continuous use of inhaled corticosteroids improve outcomes in mild asthma? A double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

When can personal best peak flow be determined for asthma action plans?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Risk of severe asthma episodes predicted from fluctuation analysis of airway function

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Daily versus as-needed corticosteroids for mild persistent asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Children with mild asthma: do they benefit from inhaled corticosteroids?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The analysis of peak expiratory flow data using a three-level hierarchical model

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Use of changes in symptoms to predict changes in lung function in assessing the response to asthma therapy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Standardisation of spirometry

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Repeatability of Spirometry in 18,000 Adult Patients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The current dilemma with spirometric inclusion criteria for asthma drug trials

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Interpretative strategies for lung function tests

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Spirometric reference values from a sample of the general U.S. population

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Physiologic measures: pulmonary function tests. Asthma outcome

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Variability of FVC and FEV1 due to technician, team, device and subject in an eight centre study: three quality control studies in SAPALDIA. Swiss Study on Air Pollution and Lung Disease in Adults

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP)

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Is forced expiratory volume in one second the best measure of severity in childhood asthma?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Clinical comparison of fenoterol and albuterol administered by inhalation. A double-blind study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Bronchial CD8 cell infiltrate and lung function decline in asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Significant variability in response to inhaled corticosteroids for persistent asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Relationships among quality of life, severity, and control measures in asthma: an evaluation using factor analysis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Development and validation of a questionnaire to measure asthma control.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Correlation of airway obstruction and patient-reported endpoints in clinical studies

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Variability and lack of predictive ability of asthma end-points in clinical trials

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Agreement among measures of asthma status: a prospective study of low-income children with moderate to severe asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Clinical predictors of health-related quality of life depend on asthma severity

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Progression of asthma measured by lung function in the childhood asthma management program

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Relationship between lung function and asthma symptoms in patients with difficult to control asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Mortality and markers of risk of asthma death among 1,075 outpatients with asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Asthma severity and asthma control: symptoms, pulmonary function, and inflammatory markers

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV(1) in primary care patients presenting with a persistent cough?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effect of deep inspiration on airway caliber in children with asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Bronchodilator response in 3-6.5 years old healthy and stable asthmatic children.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The forced oscillation technique in clinical practice: methodology, recommendations and future developments.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Indirect airway challenges

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Responsiveness to three bronchial provocation tests in patients with asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The bronchoprotective effect of inhaling methacholine by using total lung capacity inspirations has a marked influence on the interpretation of the test result

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Comparison of the forced oscillation technique and the interrupter technique for assessing airway obstruction and its reversibility in children.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Acceptability, reproducibility, and sensitivity of forced expiratory volumes and peak expiratory flow during bronchial challenge testing in asthmatic children

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Repeatability of Histamine Bronchial Challenge and Comparability with Methacholine Bronchial Challenge in a Population of Australian Schoolchildren

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Reference values for methacholine reactivity (SAPALDIA study).

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Repeatability of bronchial hyperresponsiveness to adenosine-5'-monophosphate (AMP) by a short dosimeter protocol

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Dose response of inhaled corticosteroids on bronchial hyperresponsiveness: a meta-analysis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Inter-relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper-reactivity to methacholine in asthma; a systematic bronchoalveolar lavage and airway biopsy analysis.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Influence of natural antigenic exposure on expiratory flows, methacholine responsiveness, and airway inflammation in mild allergic asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Duration of postviral airway hyperresponsiveness in children with asthma: effect of atopy.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Airway hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Airway responsiveness in early infancy predicts asthma, lung function, and respiratory symptoms by school age.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Risk factors for hospital admission for asthma from childhood to young adulthood: a longitudinal population study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: the Normative Aging Study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Irreversible lung function deficits in young adults with a history of childhood asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Characterization of within-subject responses to fluticasone and montelukast in childhood asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Bronchial thermoplasty for asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Is overall asthma control being achieved? A hypothesis-generating study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Asthma control versus asthma severity

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Achieving guideline-based asthma control: does the patient benefit?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Clinical practice guidelines: medical follow-up of patients with asthma--adults and adolescents.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Primary prevention of asthma and allergy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Rate of response of individual asthma control measures varies and may overestimate asthma control: an analysis of the goal study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Validation of a guideline-based composite outcome assessment tool for asthma control

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Assessment of asthma control in a general population of asthmatics

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Association of asthma control with health care utilization: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Bank One's worksite-based asthma disease management program

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Improved asthma outcomes using a coordinated care approach in a large medical group

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Using an asthma control questionnaire and administrative data to predict health-care utilization

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The use of induced sputum to investigate airway inflammation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Monitoring response to treatment in asthma management: food for thought.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Exhaled breath condensate: methodological recommendations and unresolved questions.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Use of exhaled nitric oxide measurements to guide treatment in chronic asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Total Eosinophil Counts in the Management of Bronchial Asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Safety and application of induced sputum analysis in childhood asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The influence of age on induced sputum differential cell counts in normal subjects.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Non-eosinophilic cor ticosteroid unresponsive asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Prednisone-dependent asthma: inflammatory indices in induced sputum

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Eosinophilic bronchitis: clinical manifestations and implications for treatment

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Cluster analysis and clinical asthma phenotypes.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Nitric oxide in health and disease of the respiratory system

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Exhaled nitric oxide measurements: clinical application and interpretation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Reference values for exhaled nitric oxide (reveno) study.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Reference ranges for exhaled nitric oxide derived from a random community survey of adults

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Exhaled nitric oxide: independent effects of atopy, smoking, respiratory tract infection, gender and height.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Transient decrease of exhaled nitric oxide after acute exposure to passive smoke in healthy subjects.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Sex differences in concentrations of exhaled nitric oxide and plasma nitrate.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Exhaled nitric oxide: the effects of age, gender and body size.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Factors affecting exhaled nitric oxide measurements: the effect of sex

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Exhaled nitric oxide: a predictor of steroid response

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Comparison of exhaled nitric oxide analysers.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

A comparison of exhaled nitric oxide measurements performed using three different analysers.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Expired nitric oxide levels during treatment of acute asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Increased nitric oxide in exhaled air of asthmatic patients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Circadian variations in serum eosinophil cationic protein, and serum and urine eosinophil protein X.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The promoter polymorphism in the eosinophil cationic protein gene and its influence on the serum eosinophil cationic protein level.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Serum eosinophil cationic protein: distribution and reproducibility in a randomly selected sample of men living in rural Norfolk, UK.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Eosinophils and eosinophilic cationic protein in induced sputum and blood: effects of budesonide and terbutaline treatment

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Influence of different dosage schedules of inhaled fluticasone propionate on peripheral blood cytokine concentrations in childhood asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled corticosteroid dose in asthmatic patients.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Reducing asthma morbidity in the community: the effect of a targeted nurse-run asthma clinic in an English general practice

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Stepping down inhaled corticosteroids in asthma: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Impact of nurse-led outpatient management of children with asthma on healthcare resource utilisation and costs

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Are peak flow and symptom measures good predictors of asthma hospitalizations and unscheduled visits?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The relationship of frequency of follow-up visits to asthma outcomes in patients with moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Randomized controlled economic evaluation of asthma self-management in primary health care

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Asthma symptoms, morbidity, and antiinflammatory use in inner-city children

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Deaths certified as asthma and use of medical services: a national case-control study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Agreement between caregiver reported healthcare utilization and administrative data for children with asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Cost-effectiveness of fluticasone propionate administered via metered-dose inhaler plus babyhaler spacer in the treatment of asthma in preschool-aged children

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

A controlled trial of an environmental tobacco smoke reduction intervention in low-income children with asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Corticosteroid use after hospital discharge among high-risk adults with asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Variation in the distribution of patient-reported outcomes based on different definitions of defining asthma severity.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Quality of life in asthma: a comparison of community and hospital asthma patients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Severe asthma in adults: what are the important questions?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Omalizumab (Xolair) improves quality of life in adult patients with allergic asthma: a review

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Impact of inhaled salmeterol/fluticasone propionate combination product versus budesonide on the health-related quality of life of patients with asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Influence of asthma education on asthma severity, quality of life and environmental control.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Interpreting changes in quality-of-life score in N of 1 randomized trials

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ).

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Commentary--goodbye M(C)ID! Hello MID, where do you come from?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Evaluation of patient's Health-Related Quality of Life using a modified and shortened version of the Living With Asthma Questionnaire (ms-LWAQ) and the medical outcomes study, Short-Form 36 (SF-36).

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Possible maximal change in the SF-36 of outpatients with chronic obstructive pulmonary disease and asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Field testing of a European quality of life instrument for children and adolescents with chronic conditions: the 37-item DISABKIDS Chronic Generic Module.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Validation of a standardized version of the Asthma Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dip

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Asthma quality of life during 1 year of treatment with budesonide with or without formoterol.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Measuring quality of life in children with asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Measuring quality of life in the parents of children with asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

A scale for the measurement of quality of life in adults with asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The Marks Asthma Quality of Life Questionnaire: further validation and examination of responsiveness to change

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Validity of a modified version of the Marks Asthma Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Health-related quality of life in asthma: a comparison between the St George's Respiratory Questionnaire and the Asthma Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Repeatability of a Rasch model of the AQ20 over five assessments.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

The correlation between asthma control and health status: the GOAL study.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Near-fatal asthma phenotype in the ENFUMOSA Cohort

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-060ST

21 January 2018

Identifiers

10.1164/RCCM.200801-060ST

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37522916&oldid=1837455873"